Before joining MODAG as CMO, Prof. Dr. Levin was Head of the Outpatient Clinic for Neurodegenerative Diseases at the Department of Neurology at the Ludwig Maximilian University (LMU) in Munich, Germany, and Deputy Head of Clinical Research at the German Center for Neurodegenerative Diseases (DZNE) in Munich. He is continuing to exercising these responsibilities at a 50% capacity-rate.

Prof. Levin has been working in the field of neurodegeneration for more than 15 years. His principal research focus is the molecular pathogenesis of neurodegenerative diseases, especially on protein aggregation and therapy development targeting pathological protein aggregates. He is principal investigator in international cohort studies such as the Dominantly Inherited Alzheimer’s Network (DIAN) and the Genetic Fronto-temporal dementia Initiative (GENFI-2). His research contributed to the definition of the natural history, environmental factors, and symptomatic treatment of neurodegenerative diseases. Moreover, he has a proven track record for coordinating academic research studies including one of the largest recent interventional trials in Multiple System Atrophy.